Stallergenes Greer Is A Global Biopharmaceutical Company Focused On Diagnosing And Treating Allergies Through Allergen Immunotherapyait Formed In 2015 From The Merger Of Stallergenes And Greer Laboratories Inc The Company Combines Nearly 120 Years Of Expertise In The Fieldheadquartered In Baarswitzerlandstallergenes Greer Operates As A Privately Held Entity And Employs Approximately 1 129 People Worldwide The Company Offers A Wide Range Of Productsincluding Subcutaneous And Sublingual Drops And Tablets For Allergen Immunotherapyaddressing Both Respiratory And Food Allergiesstallergenes Greer Also Provides Solutions For Veterinary Allergieswith Manufacturing Facilities In Europethe Usaand Canadathe Company Has A Strong Distribution Network Active In 44 Countriesmaking It A Significant Player In The Global Allergy Treatment Marketits Commitment To Personalized Treatments Ensures That Its Services Meet The Diverse Needs Of Patients And Healthcare Providers Around The World
